Project 2: Peptide imaging agents for early targets in progression from BE to EAC
项目 2:用于从 BE 到 EAC 进展的早期靶点的肽显像剂
基本信息
- 批准号:10155439
- 负责人:
- 金额:$ 31.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-21 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntibodiesAppearanceArchitectureAreaBarrett EsophagusBarrett&aposs neoplasiaBindingBiodistributionBiologicalBiologyBiopsyCell surfaceClinicalClinical ResearchDetectionDiagnosticDiagnostic ProcedureDistalERBB2 geneEndoscopesEndoscopyEpidermal Growth Factor ReceptorEpitopesEsophageal AdenocarcinomaEsophagusEventEvolutionExtracellular DomainFGFR2 geneFiberFoundationsGene AmplificationGene ExpressionGene FrequencyGeneticHealthcareHumanImageIncidenceInterventionLabelLeadLesionLigandsLightMalignant NeoplasmsMapsMedicalMethodsMolecularMucous MembraneMutationPatientsPeptidesPerformancePhage DisplayPreventive measurePropertyResearchResearch Project GrantsRiskSafetyScreening for cancerSignal PathwaySmall Interfering RNASocietiesSpatial DistributionSpecificitySurfaceTimeTissuesTopical applicationToxic effectValidationbasecare burdenchromoscopycontrast imagingcostdimerfallsfirst-in-humanflexibilityfluorophoreimaging agentimaging approachimprovedin vivoin vivo imaginginsightinstrumentknock-downminimal riskmonomernoveloverexpressionpreventrecruitstomach cardiatargeted agenttargeted deliverytargeted imagingtool
项目摘要
Abstract – This research project falls under effects of spatial distribution of genetic alterations in BE on the
evolution of EAC as one of the areas defined in RFA-CA-16-006. We have previously identified EGFR and
ErbB2 based on high-frequency gene amplification using gene expression profiles as cell surface targets for
imaging of EAC and have developed monomer peptides specific for these targets. We now aim to develop
new peptides specific for early targets that arise in progression from BE to EAC to be identified in Project 1.
Recently, we have identified a monomer peptide that is specific for the early target FGFR2. Because genetic
events that drive progression of BE to EAC can be occur in multiple signaling pathways, we will develop a
panel of overexpressed targets to detect the largest percentage of patients with HGD and early EAC. Because
early targets are expected to be expressed at low levels, we will arrange validated monomers in a dimer
configuration to produce multivalent ligand-target interactions for improving binding performance. This effect is
used by antibodies to achieve very high binding affinity and specificity. Higher sensitivity can occur from
simultaneous detection of two unique targets. Greater specificity may arise from dimer binding to larger
regions of target epitope compared with that of monomer. We will use fluorophores as labels that emit with
non-overlapping spectra for imaging with a flexible fiber multi-spectral endoscope. The instrument is small
enough to pass through the working channel of a standard medical endoscope, and can image the mucosal
surface of the distal esophagus in real time to guide tissue biopsy. We will perform “first-in-human” clinical
studies to establish safety and provide early evidence of efficacy for this novel, integrated imaging approach.
Successful completion of the aims will result in a panel of monomer peptides specific for early targets that
arise in progression of BE to EAC that are arranged as dimers and clinical demonstrated for safety and early
evidence of efficacy.
摘要 - 该研究项目属于遗传改变的空间分布在BE上的影响
EAC作为RFA-CA-16-006中定义的区域之一的演变。我们以前已经确定了EGFR和
基于高频基因扩增的ERBB2,使用基因表达谱作为细胞表面靶标
EAC的成像,并开发了针对这些靶标的特定于这些靶标的单体。我们现在旨在发展
针对从BE到EAC的早期靶标特有的新肽在项目1中鉴定出来。
最近,我们确定了一种针对早期靶标FGFR2的单体肽。因为遗传
可以在多个信号通路中发生驱动BE向EAC的事件发生,我们将开发一个
过表达目标的面板可检测HGD和EAC早期患者的最大百分比。因为
预计早期目标将以低级别表示,我们将在二聚体中安排经过验证的单体
配置可产生多价配体 - 靶标相互作用,以改善结合性能。这种效果是
抗体用于实现非常高的结合亲和力和特异性。从
简单检测两个独特的目标。二聚体与较大的二聚体可能产生更大的特异性
与月相比,目标表位区域的区域。我们将使用荧光团作为发出的标签
具有柔性纤维多光谱内窥镜成像成像的非重叠光谱。乐器很小
足以通过标准医疗内窥镜的工作渠道,并可以对粘膜进行成像
实时的食管远端表面引导组织活检。我们将执行“人类第一”临床
为建立安全性并为这种新颖的综合成像方法提供效率的早期证据。
成功完成目标将导致一个单体小组针对早期目标的特定于
出现在BE向EAC的进展中,该EAC被排列为二聚体,并在临床上证明了安全性和早期
效率的证据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas D Wang其他文献
Thomas D Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas D Wang', 18)}}的其他基金
Early detection of colorectal cancer in the traditional and serrated pathways
通过传统途径和锯齿状途径早期发现结直肠癌
- 批准号:
10471944 - 财政年份:2020
- 资助金额:
$ 31.68万 - 项目类别:
Early detection of colorectal cancer in the traditional and serrated pathways
通过传统途径和锯齿状途径早期发现结直肠癌
- 批准号:
10244933 - 财政年份:2020
- 资助金额:
$ 31.68万 - 项目类别:
Early detection of colorectal cancer in the traditional and serrated pathways
通过传统途径和锯齿状途径早期发现结直肠癌
- 批准号:
9974634 - 财政年份:2020
- 资助金额:
$ 31.68万 - 项目类别:
Early Detection of Colorectal Cancer on Near-Infrared Molecular Endoscopy
近红外分子内窥镜早期发现结直肠癌
- 批准号:
9922878 - 财政年份:2016
- 资助金额:
$ 31.68万 - 项目类别:
Early Detection of Colorectal Cancer on Near-Infrared Molecular Endoscopy
近红外分子内窥镜早期发现结直肠癌
- 批准号:
9030043 - 财政年份:2016
- 资助金额:
$ 31.68万 - 项目类别:
Multiplexed Multi-Modal Endoscopic Imaging of Cancer Biomarkers
癌症生物标志物的多重多模态内窥镜成像
- 批准号:
8890458 - 财政年份:2015
- 资助金额:
$ 31.68万 - 项目类别:
Project 2: Peptide imaging agents for early targets in progression from BE to EAC
项目 2:用于从 BE 到 EAC 进展的早期靶点的肽显像剂
- 批准号:
10268346 - 财政年份:2011
- 资助金额:
$ 31.68万 - 项目类别:
相似国自然基金
募集HBV抗体用于肿瘤免疫治疗的分子设计及作用机制
- 批准号:22377041
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
双特异性抗体囊泡对胞内细菌感染的免疫综合机制研究
- 批准号:82304366
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
四种停用喹诺酮类药物高分辨力单克隆抗体的精准制备及其识别机制研究
- 批准号:32373059
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DHEA协同别构纳米抗体通过ADGRG2调控男性生殖功能障碍的作用及机制
- 批准号:82371629
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Maturation of human humoral immunity through repeat malaria challenges
通过重复疟疾挑战使人体体液免疫成熟
- 批准号:
10720245 - 财政年份:2023
- 资助金额:
$ 31.68万 - 项目类别:
Insights into erythropoietin homeostasis: Identifying the autoantigen targeted in the TEMPI syndrome
深入了解促红细胞生成素稳态:识别 TEMPI 综合征中针对的自身抗原
- 批准号:
10511508 - 财政年份:2022
- 资助金额:
$ 31.68万 - 项目类别:
Virulent Rickettsia species utilize the CD300f phosphatidylserine-binding receptor on macrophages for host colonization and pathogenesis
强毒立克次体利用巨噬细胞上的 CD300f 磷脂酰丝氨酸结合受体进行宿主定植和发病机制
- 批准号:
10674996 - 财政年份:2022
- 资助金额:
$ 31.68万 - 项目类别:
Insights into erythropoietin homeostasis: Identifying the autoantigen targeted in the TEMPI syndrome
深入了解促红细胞生成素稳态:识别 TEMPI 综合征中针对的自身抗原
- 批准号:
10661092 - 财政年份:2022
- 资助金额:
$ 31.68万 - 项目类别:
The Role of the Host Ubiquitin System in Promoting SARS-CoV-2 replication and Pathogenesis
宿主泛素系统在促进 SARS-CoV-2 复制和发病机制中的作用
- 批准号:
10681941 - 财政年份:2021
- 资助金额:
$ 31.68万 - 项目类别: